[1]
S. Y. C., M. Sethi, T. Barsinge, Y. Kamath, and K. A. S., “A follow up study of warning letters issued by US Food and Drug Administration to clinical investigators, institutional review boards and sponsors: a situational analysis during COVID-19 pandemic”, Int J Res Med Sci, vol. 13, no. 4, pp. 1587–1593, Mar. 2025.